Login Register Cart 0
Generic placeholder image

Current Pharmaceutical Biotechnology

Editor-in-Chief

ISSN (Print): 1389-2010
ISSN (Online): 1873-4316

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Does Nimodipine, a Selective Calcium Channel Blocker, Impair Chondrocyte Proliferation or Damage Extracellular Matrix Structures?

Author(s): Necati Kaplan, Ibrahim Yilmaz, Numan Karaarslan*, Yasin E. Kaya, Duygu Y. Sirin and Hanefi Ozbek

Volume 20, Issue 6, 2019

Page: [517 - 524] Pages: 8

DOI: 10.2174/1389201020666190506124548

open access plus

Abstract

Background: The study aimed to investigate the effects of the active ingredient, nimodipine, on chondrocyte proliferation and extracellular matrix (ECM) structures in cartilage tissue cells.

Methods: Chondrocyte cultures were prepared from tissues resected via surgical operations. Nimodipine was then applied to these cultures and molecular analysis was performed. The data obtained were statistically calculated.

Results: Both, the results of the (3-(4,5 dimethylthiazol2-yl)-2,5-diphenyltetrazolium (MTT) assay and the fluorescence microscope analysis [a membrane permeability test carried out with acridine orange/ propidium iodide staining (AO/PI)] confirmed that the active ingredient, nimodipine, negatively affects the cell cultures.

Conclusion: Nimodipine was reported to suppress cellular proliferation; chondroadherin (CHAD) and hypoxia-inducible factor-1 alpha (HIF-1α) expression thus decreased by 2.4 and 1.7 times, respectively, at 24 hrs when compared to the control group (p < 0.05). Furthermore, type II collagen (COL2A1) expression was not detected (p < 0.05). The risk that a drug prescribed by a clinician in an innocuous manner to treat a patient by relieving the symptoms of a disease may affect the proliferation, differentiation, and viability of other cells and/or tissues at the molecular level, beyond its known side effects or adverse events, should not be forgotten.

Keywords: Chondroadherin, chondrocyte, hypoxia-inducible factor-1 alpha, nimodipine, type II collagen, matrix structures.

« Previous
Graphical Abstract

[1]
Pillai, S.V.; Kolluri, V.R.; Mohanty, A.; Chandramouli, B.A. Evaluation of nimodipine in the treatment of severe diffuse head injury: a double-blind placebo-controlled trial. Neurol. India, 2003, 51(3), 361-363. [PMID: 14652439].
[2]
Barker, F.G., II; Heros, R.C. Clinical aspects of vasospasm. Neurosurg. Clin. N. Am., 1990, 1(2), 277-288. [http://dx.doi.org/10.1016/S1042-3680(18)30804-0]. [PMID: 2136141].
[3]
Fleckenstein-Grün, G.; Fleckenstein, A. Prevention of cerebrovascular spasms with nimodipine. Stroke, 1990, 21(12 Suppl.), IV64-IV71. [PMID: 2260151].
[4]
Langham, J.; Goldfrad, C.; Teasdale, G.; Shaw, D.; Rowan, K. Calcium channel blockers for acute traumatic brain injury. Cochrane Database Syst. Rev., 2003, (4), CD000565. [http://dx.doi.org/10.1002/14651858.CD000565]. [PMID: 14583925].
[5]
Lee, S.H.; Yun, S.J.; Choi, Y.H. Reversible cerebral vasoconstriction syndrome presenting as subarachnoid hemorrhage: A rare cause of postpartum seizure. Am. J. Emerg. Med., 2017, 35(5) [http://dx.doi.org/10.1016/j.ajem.2016.12.021].
[6]
Martins, Y.C.; Clemmer, L.; Orjuela-Sánchez, P.; Zanini, G.M.; Ong, P.K.; Frangos, J.A.; Carvalho, L.J. Slow and continuous delivery of a low dose of nimodipine improves survival and electrocardiogram parameters in rescue therapy of mice with experimental cerebral malaria. Malar. J., 2013, 12, 138. [http://dx.doi.org/10.1186/1475-2875-12-138]. [PMID: 23617605].
[7]
Song, X.; Jiang, Y.; Ren, C.; Sun, X.; Zhang, Q.; Gong, T.; Zhang, Z. Nimodipine-loaded mixed micelles: Formulation, compatibility, pharmacokinetics, and vascular irritability study. Int. J. Nanomedicine, 2012, 7, 3689-3699. [PMID: 22888228].
[8]
Chen, N.X.; Kircelli, F.; O’Neill, K.D.; Chen, X.; Moe, S.M. Verapamil inhibits calcification and matrix vesicle activity of bovine vascular smooth muscle cells. Kidney Int., 2010, 77(5), 436-442. [http://dx.doi.org/10.1038/ki.2009.481]. [PMID: 20016465].
[9]
Karaarslan, N.; Batmaz, A.G.; Yilmaz, I.; Ozbek, H.; Caliskan, T.; Yasar Sirin, D.; Kaplan, N.; Oznam, K.; Ates, O. Effect of naproxen on proliferation and differentiation of primary cell cultures isolated from human cartilage tissue. Exp. Ther. Med., 2018, 16(3), 1647-1654. [http://dx.doi.org/10.3892/etm.2018.6351]. [PMID: 30186383].
[10]
Isyar, M.; Yilmaz, I.; Yasar Sirin, D.; Yalcin, S.; Guler, O.; Mahirogullari, M. A practical way to prepare primer human chondrocyte culture. J. Orthop., 2016, 13(3), 162-167. [http://dx.doi.org/10.1016/j.jor.2016.03.008]. [PMID: 27408489].
[11]
Sirin, D.Y.; Kaplan, N.; Yilmaz, I.; Karaarslan, N.; Ozbek, H.; Akyuva, Y.; Kaya, Y.E.; Oznam, K.; Akkaya, N.; Guler, O.; Akkaya, S.; Mahirogullari, M. The association between different molecular weights of hyaluronic acid and CHAD, HIF-1α, COL2A1 expression in chondrocyte cultures. Exp. Ther. Med., 2018, 15(5), 4205-4212. [http://dx.doi.org/10.3892/etm.2018.5943]. [PMID: 29849772].
[12]
Karaarslan, N.; Yilmaz, I.; Ozbek, H.; Yasar Sirin, D.; Kaplan, N.; Caliskan, T.; Ozdemir, C.; Akyuva, Y.; Ates, O. Are radio-contrast agents commonly used in discography toxic to the intact intervertebral disc tissue cells? Basic Clin. Pharmacol. Toxicol., 2019, 124(2), 181-189. [http://dx.doi.org/10.1111/bcpt.13112]. [PMID: 30120906].
[13]
Karaarslan, N.; Yilmaz, I.; Sirin, D.Y.; Baykiz, D.; Demirkiran, A.; Ates, O. Do we damage nucleus pulposus tissue while treating cerebrovascular ischemic neurological deficits with nimodipine? Ann. Med. Res., 2018, 25(2), 266-273. [http://dx.doi.org/10.5455/jtomc.2018.04.063].
[14]
Sirin, D.Y.; Karaarslan, N. Evaluation of the effects of pregabalin on chondrocyte proliferation and CHAD, HIF-1α, and COL2A1 gene expression. Arch. Med. Sci., 2018, 14(6), 1340-1347. [http://dx.doi.org/10.5114/aoms.2018.73134]. [PMID: 30393488].
[15]
Karaarslan, N.; Yilmaz, I.; Sirin, D.Y.; Ozbek, H.; Kaplan, N.; Kaya, Y.E.; Akyuva, Y.; Gurbuz, M.S.; Oznam, K.; Ates, O. Pregabalin treatment for neuropathic pain may damage intervertebral disc tissue. Exp. Ther. Med., 2018, 16(2), 1259-1265. [http://dx.doi.org/10.3892/etm.2018.6289]. [PMID: 30112057].
[16]
Caliskan, T.; Sirin, D.Y.; Karaarslan, N.; Yilmaz, I.; Ozbek, H.; Akyuva, Y.; Kaplan, N.; Kaya, Y.E.; Simsek, A.T.; Guzelant, Y.A.; Ates, O. Is Etanercept, which is a Tumour Necrosis Factor receptor fusion protein, cytotoxic to primary human cell cultures isolated from intact intervertebral disc tissue? Exp. Ther. Med., 2019. Epub ahead of print
[17]
Buendia, I.; Tenti, G.; Michalska, P.; Méndez-López, I.; Luengo, E.; Satriani, M.; Padín-Nogueira, F.; López, M.G.; Ramos, M.T.; García, A.G.; Menéndez, J.C.; León, R. Addition to “ITH14001, a CGP37157-nimodipine hybrid designed to regulate calcium homeostasis and oxidative stress, exerts neuroprotection in cerebral ischemia”. ACS Chem. Neurosci., 2017, 8(1), 210. [http://dx.doi.org/10.1021/acschemneuro.6b00364]. [PMID: 28095680].
[18]
von der Brelie, C.; Doukas, A.; Stopfer, A.; Larsen, N.; Mehdorn, M.; Synowitz, M.; Jansen , O. von der, Brelie, C.; Doukas, A.; Stopfer, A.; Larsen, N.; Mehdorn, M.; Synowitz, M.; Jansen, O. Clinical course and monitoring parameters after continuous interventional intra-arterial treatment in patients with refractory cerebral vasospasm. World Neurosurg., 2017, 100, 504-513. [http://dx.doi.org/10.1016/j.wneu.2016.12.110]. [PMID: 28131927].
[19]
Rämisch, S.; Pramhed, A.; Tillgren, V.; Aspberg, A.; Logan, D.T. Crystal structure of human chondroadherin: Solving a difficult molecular-replacement problem using de novo models. Acta Crystallogr. D Struct. Biol., 2017, 73(Pt 1), 53-63. [http://dx.doi.org/10.1107/S205979831601980X]. [PMID: 28045385].
[20]
Shangguan, L.; Ning, G.; Luo, Z.; Zhou, Y. Fibulin-4 reduces extracellular matrix production and suppresses chondrocyte differentiation via DKK1- mediated canonical Wnt/β-catenin signaling. Int. J. Biol. Macromol., 2017, 99, 293-299. [http://dx.doi.org/10.1016/j.ijbiomac.2017.02.087]. [PMID: 28238906].
[21]
Zelzer, E.; Mamluk, R.; Ferrara, N.; Johnson, R.S.; Schipani, E.; Olsen, B.R. VEGFA is necessary for chondrocyte survival during bone development. Development, 2004, 131(9), 2161-2171. [http://dx.doi.org/10.1242/dev.01053]. [PMID: 15073147].
[22]
Erol, K.; Yiğitaslan, S.; Ünel, Ç.; Kaygısız, B.; Yıldırım, E. Evaluation of cisplatin neurotoxicity in cultured rat dorsal root ganglia via cytosolic calcium accumulation. Balkan Med. J., 2016, 33(2), 144-151. [http://dx.doi.org/10.5152/balkanmedj.2016.161110]. [PMID: 27403382].
[23]
Zhu, J.J.; Xu, Y.Q.; He, J.H.; Yu, H.P.; Huang, C.J.; Gao, J.M.; Dong, Q.X.; Xuan, Y.X.; Li, C.Q. Human cardiotoxic drugs delivered by soaking and microinjection induce cardiovascular toxicity in zebrafish. J. Appl. Toxicol., 2014, 34(2), 139-148. [http://dx.doi.org/10.1002/jat.2843]. [PMID: 23307606].
[24]
Turner, C.P.; Miller, R.; Smith, C.; Brown, L.; Blackstone, K.; Dunham, S.R.; Strehlow, R.; Manfredi, M.; Slocum, P.; Iverson, K.; West, M.; Ringler, S.L.; Berry, Z.C. Widespread neonatal brain damage following calcium channel blockade. Dev. Neurosci., 2007, 29(3), 213-231. [http://dx.doi.org/10.1159/000095221]. [PMID: 16921238].

Rights & Permissions Print Cite
Article Metrics
57
5
© 2024 Bentham Science Publishers | Privacy Policy